Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Clinical trial NCT04140123 · COMPLETED
Trial details
- NCT number
- NCT04140123
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-23
- Primary completion
- 2021-08-03
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.